Stock Research for CMRX


Featured Broker: Ally Invest

Get the due diligence for another stock.


CMRX Stock Chart & Research Data

The CMRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CMRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CMRX Due diligence Resources & Stock Charts

The CMRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CMRX Detailed Price Forecast - CNN Money CNN View CMRX Detailed Summary - Google Finance
Yahoo View CMRX Detailed Summary - Yahoo! Finance Zacks View CMRX Stock Research & Analysis -

Stock Analysis

TradeIdeas View CMRX Trends & Analysis - Trade-Ideas Barrons View CMRX Major Holders - Barrons
NASDAQ View CMRX Call Transcripts - NASDAQ Seeking View CMRX Breaking News & Analysis - Seeking Alpha
Spotlight View CMRX Annual Report - OTC Report View CMRX OTC Short Report -
TradeKing View CMRX Fundamentals - TradeKing Charts View CMRX SEC Filings - Bar Chart
WSJ View Historical Prices for CMRX - The WSJ Morningstar View Performance/Total Return for CMRX - Morningstar
MarketWatch View the Analyst Estimates for CMRX - MarketWatch CNBC View the Earnings History for CMRX - CNBC
StockMarketWatch View the CMRX Earnings - StockMarketWatch MacroAxis View CMRX Buy or Sell Recommendations - MacroAxis
Bullish View the CMRX Bullish Patterns - American Bulls Short Pains View CMRX Short Pain Metrics -

Social Media Mentions

StockTwits View CMRX Stock Mentions - StockTwits PennyStocks View CMRX Stock Mentions - PennyStockTweets
Twitter View CMRX Stock Mentions - Twitter Invest Hub View CMRX Investment Forum News - Investor Hub
Yahoo View CMRX Stock Mentions - Yahoo! Message Board Seeking Alpha View CMRX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CMRX - Insider Cow View Insider Transactions for CMRX - Insider Cow
CNBC View CMRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CMRX - OTC Markets
Yahoo View Insider Transactions for CMRX - Yahoo! Finance NASDAQ View Institutional Holdings for CMRX - NASDAQ

Stock Charts

FinViz View CMRX Stock Insight & Charts - StockCharts View CMRX Investment Charts -
BarChart View CMRX Stock Overview & Charts - BarChart Trading View View CMRX User Generated Charts - Trading View

Latest Financial News for CMRX

Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference
Posted on Friday January 04, 2019

Chimerix (CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Michelle Berrey, M.D., M.P.H, President and Chief Executive Officer of Chimerix, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 10:00 a.m. PT (1:00 p.m. ET) at the Westin Saint Francis Hotel in San Francisco, CA. Dr. Berrey will present a corporate overview with plans and expected milestones for 2019, which will highlight the Company's core focus on progressing both oral, short-course brincidofovir (BCV) and the intravenous (IV) BCV program. Following planned discussions with FDA, the Company intends to progress IV BCV into a proof-of-concept study for the treatment of BK virus in kidney transplant recipients, while completing the phase 2 studies initiated during 2018 of IV BCV in adult stem cell transplant recipients with adenovirus infection.

Should You Avoid Chimerix Inc (CMRX)?
Posted on Saturday December 22, 2018

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in October, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. […]

5 Beaten-Down Medical Product Stocks to Rebound in 2019
Posted on Tuesday December 18, 2018

As the Medical product industry is witnessing temporary sluggishness, a sneak peek into some possible outperformers in 2019 could be a great idea for investors.

Is Chimerix, Inc. (NASDAQ:CMRX) Overpaying Its CEO?
Posted on Wednesday December 12, 2018

M. Berrey became the CEO of Chimerix, Inc. (NASDAQ:CMRX) in 2014. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that, we Read More...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.